C1orf51 Inhibitors
Chemical inhibitors of C1orf51 play a significant role in modulating its function through various intracellular signaling pathways. Staurosporine, a powerful kinase inhibitor, directly targets the phosphorylation process that is crucial for the activity of many proteins, including C1orf51. By preventing this phosphorylation, staurosporine can impair the functional activity of C1orf51. Similarly, U0126 and PD98059, both MEK inhibitors, disrupt the MAPK/ERK pathway, which is essential for the propagation of signals that may be necessary for C1orf51's role in circadian regulation. KN-93, which selectively inhibits Ca2+/calmodulin-dependent protein kinase II, affects the calcium signaling that has been associated with the regulation of circadian rhythms, which C1orf51 is believed to be a part of. This inhibition can alter the normal functioning of C1orf51, highlighting the intricate relationship between calcium signaling and circadian regulation.
Further chemical inhibitors that affect C1orf51 function include LY294002 and Wortmannin, both of which are PI3K inhibitors. By inhibiting PI3K, these chemicals disrupt signaling pathways that influence circadian clocks, potentially altering the functioning of C1orf51. Rapamycin, by inhibiting mTOR, can also affect circadian rhythm regulation, which may intersect with the functional role of C1orf51. Inhibitors like SB203580, which acts on p38 MAPK, and Sp600125, which targets JNK, can disrupt additional signaling pathways relevant to stress responses and circadian rhythm regulation, thereby influencing C1orf51 activity. PKC inhibitors such as Chelerythrine and Go6983, as well as the broad-spectrum kinase inhibitor K252a, can also modulate signal transduction pathways that are integral to the regulation of circadian rhythms, resulting in functional inhibition of C1orf51. Each of these chemical inhibitors targets specific kinases or pathways, which are interconnected with the functional role of C1orf51, demonstrating the complexity of its regulation within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Given that C1orf51 is implicated in circadian rhythms which rely heavily on phosphorylation events, staurosporine can inhibit the kinases that modify C1orf51, resulting in its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK/ERK pathway. C1orf51, involved in the circadian regulation, may require ERK signaling for proper function, and U0126-mediated inhibition of MEK could thus lead to functional inhibition of C1orf51. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII is involved in numerous cellular processes including the regulation of circadian rhythms which C1orf51 is a part of, hence inhibition of CaMKII by KN-93 can inhibit the function of C1orf51. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K signaling can influence circadian clocks and related proteins. Inhibition of PI3K by LY294002 can disrupt the signaling required for C1orf51 function in circadian rhythm regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, similar to LY294002, and it can inhibit the PI3K-Akt pathway. Since this pathway may intersect with circadian rhythm signaling, wortmannin can functionally inhibit C1orf51 by disrupting its associated signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, and mTOR signaling is connected to circadian rhythm regulation. By inhibiting mTOR, rapamycin could functionally inhibit C1orf51 through the disruption of this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. As ERK signaling can be involved in circadian rhythm control, PD98059 can inhibit the functional activity of C1orf51 by interrupting this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Given that p38 MAPK can be involved in stress responses that intersect with circadian rhythms, SB203580 can inhibit the function of C1orf51 by blocking this signaling route. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Sp600125 is an inhibitor of JNK, which plays a role in various cellular processes including circadian rhythm regulation. Inhibition of JNK by Sp600125 can result in functional inhibition of C1orf51. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a potent inhibitor of protein kinase C (PKC), which is involved in signal transduction for various cellular processes that could intersect with the pathways involving C1orf51, leading to its functional inhibition. | ||||||